IL1B and intervertebral disk degenerative disorder: In vitro and in vivo studies of IDD have demonstrated that AS-IV reduces IL-1β-induced inflammation, apoptosis, and ECM degradation, and protects against IDD progression in needle-puncture rat models (Tian et al., 2022).